Integrated Fluidics Inc.
A revolutionary new approach to improving the performance of bioassays in life science research and clinical diagnostics.
The Company is developing an electrokinetic bioassay platform that addresses critical bottlenecks in the discovery and development of new treatments as well as the performance of time-critical diagnostic tests. Sensitivity is improved 100x, reaction kinetics are accelerated 15x and reagent consumption is reduced 25x - without changes to existing workflow. The result is enhanced laboratory productivity and significantly reduced overall cost/test.